Loading...
Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2
The spread of new coronavirus infection starting December 2019 as novel SARS-CoV-2, identified as the causing agent of COVID-19, has affected all over the world and been declared as pandemic. Approximately, more than 8,807,398 confirmed cases of COVID-19 infection and 464,483 deaths have been report...
Saved in:
| Published in: | J Biomol Struct Dyn |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7484586/ https://ncbi.nlm.nih.gov/pubmed/32752944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1802345 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|